InsidersTradesSigma
Follow the COMBIGENE AB share price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. The latest transaction was disclosed on 1 April 2021 (Purchase). Among the most active insiders: Peter Nilsson. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
COMBIGENE AB is a biopharmaceutical company focused on developing treatments for genetic and neurological diseases. It is listed on the XSTO market.